North America Sleep Disorder Treatment Market - Industry Trends and Forecast to 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	180 Pages	Data Bridge Market Research	February, 2022	DAABD17290112

Best Price Guarantee
Price	from $3,500
Length	180 Pages
Publisher	Data Bridge Market Research
Published Date	February, 2022
SKU	DAABD17290112

North America Sleep Disorder Treatment Market - Industry Trends and Forecast to 2028

North America sleep disorder treatment market is projected to register a substantial CAGR of 8.6% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation:
North America Sleep Disorder Treatment Market, By Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy, and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery, and Others), Route of Administration (Oral, Parenteral, and Others), Drugs Type (Branded and Generics), Population Type (Children and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (U.S, Canada and Mexico) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of the North America sleep disorder treatment market are:

. The growing popularity of mechanical therapy devices to cure sleep disorders across the globe
. Technological advancements in sleep disorder treatment
Market Players:

The key market players for North America sleep disorder treatment market are listed below:

. Jazz Pharmaceuticals, Inc.
. Pfizer Inc.
. Viatris Inc.
. Arbor Pharmaceuticals
. Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
. sanofi-aventis U.S. LLC (a subsidiary of Sanofi)
. Hikma Pharmaceuticals PLC
. Amneal Pharmaceuticals LLC
. Lupin Pharmaceuticals, Inc. (a subsidiary of Lupin)
. Taj Pharmaceuticals Limited
. Eli Lilly and Company
. Mallinckrodt
. Alembic Pharmaceuticals Limited
. Apotex Inc.
. Dr. Reddy’s Laboratories Ltd.
. Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
. Taro Pharmaceutical Industries Ltd.
. Koninklijke Philips N.V.
. DeVilbiss Healthcare LLC
. ResMed
. SomnoMed
. Oventus
. BMC Medical Co.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Sleep Disorder Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Market End User Coverage Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insight
5 North America Sleep Disorder Treatment Market: Regulations
6 North America Sleep Disorder Treatment Market: Pipeline Analysis
7 Market Overview: 7.1 Drivers; 7.1.1 Rising Prevalence Of Sleeping Disorders; 7.1.2 Rise In The Geriatric Population; 7.1.3 Increase In Mental Stress Due To Hectic Life & Unhealthy Habits; 7.1.4 Large Pool Of Undiagnosed Sleep Apnea Patients; 7.1.5 Presence Of Potential Clinical Pipeline Candidates; 7.2 Restraints; 7.2.1 Side Effects Associated With These Drugs; 7.2.2 Patent Expiration Of Major Sleep Disorder Treatment Drugs; 7.2.3 Emergence Of Generics; 7.3 Opportunities; 7.3.1 Technological Advancements In The Sleep Aids In The U.S.; 7.3.2 Increasing Usage Of Social Media And Growing Addiction Of Gadgets Such As Smartphones And Laptops; 7.3.3 Growing Awareness About Target Disease; 7.4 Challenges; 7.4.1 High Cost Of Diagnosis & Treatment For Sleeping Disorder; 7.4.2 Stringent Regulatory Landscape; 7.4.3 Potential Ill-effects Due To Drug Abuse
8 Impact Of Covid-19 On North America Sleep Disorder Treatment Market: 8.1 Price Impact; 8.2 Impact On Demand; 8.3 Impact On Supply Chain; 8.4 Strategic Initiatives By Market Players During Covid-19; 8.5 Conclusion
9 North America Sleep Disorder Treatment Market, By Type: 9.1 Overview; 9.2 Insomnia; 9.2.1 Insomnia; 9.2.2 Child Insomnia; 9.2.3 Others; 9.3 Sleep Apnea; 9.3.1 Obstructive Sleep Apnea; 9.3.2 Central Sleep Apnea; 9.3.3 Snoring; 9.3.4 Infant Sleep Apnea; 9.3.5 Others; 9.4 Restless Legs Syndrome (Rls); 9.5 Narcolepsy; 9.5.1 Type 1; 9.5.2 Type 2
10 North America Sleep Disorder Treatment Market, By Treatment: 10.1 Overview; 10.2 Pharmacological Therapy; 10.2.1 Cannabidiol; 10.2.2 Anti-parkinsonian Drugs (Dopamine Agonists); 10.2.3 Benzodiazepines; 10.2.4 Non-benzodiazepine; 10.2.5 Melatonin Receptor Stimulator; 10.2.6 Stimulants; 10.2.7 Selective Serotonin Reuptake Inhibitors (Ssris) Or Serotonin And Norepinephrine Reuptake Inhibitors (Snris); 10.2.8 Tricyclic Antidepressants; 10.2.9 Sodium Oxybate (Xyrem); 10.2.10 Others; 10.3 Mechanical Therapy; 10.3.1 Cpap (Continuous Positive Airway Pressure); 10.3.2 Bi-level Pap; 10.3.3 Auto Cpap Or Auto Bi-level Pap; 10.3.4 Adaptive Servo-ventilation (Asv); 10.4 Mandibular Advancement Devices; 10.5 Hypoglossal Nerve Stimulator; 10.6 Surgery; 10.6.1 Somnoplasty; 10.6.2 Tonsillectomy; 10.6.3 Nasal Surgery; 10.6.4 Others; 10.7 Others
11 North America Sleep Disorder Treatment Market, By Route Of Administration: 11.1 Overview; 11.2 Oral; 11.2.1 Tablet; 11.2.2 Pills; 11.2.3 Others; 11.3 Parenteral; 11.4 Others
12 North America Sleep Disorder Treatment Market, By Drugs Type: 12.1 Overview; 12.2 Generics; 12.3 Branded; 12.3.1 Xyrem; 12.3.2 Effexor Xr; 12.3.3 Ambien; 12.3.4 Pristiq; 12.3.5 Zenzedi; 12.3.6 Vyvanse; 12.3.7 Others
13 North America Sleep Disorder Treatment Market, By Population Type: 13.1 Overview; 13.2 Adult; 13.3 Children
14 North America Sleep Disorder Treatment Market, By End User: 14.1 Overview; 14.2 Hospitals; 14.3 Specialty Clinics; 14.4 Home Healthcare; 14.5 Ambulatory Surgical Center; 14.6 Others
15 North America Sleep Disorder Treatment Market, By Distribution Channel: 15.1 Overview; 15.2 Direct Tender; 15.3 Hospital Pharmacy; 15.4 Retail Pharmacy; 15.5 Online Pharmacy; 15.6 Others
16 North America Sleep Disorder Treatment Market, By Region: 16.1 North America; 16.1.1 U.S.; 16.1.2 Canada; 16.1.3 Mexico
17 North America Sleep Disorder Treatment Market: Company Landscape: 17.1 Company Share Analysis: North America
18 Swot Analysis
19 Company Profile: 19.1 Jazz Pharmaceuticals, Inc.; 19.1.1 Company Snapshot; 19.1.2 Revenue Analysis; 19.1.3 Product Portfolio; 19.1.4 Recent Developments; 19.2 Pfizer Inc.; 19.2.1 Company Snapshot; 19.2.2 Revenue Analysis; 19.2.3 Product Portfolio; 19.2.4 Recent Development; 19.3 Eli Lilly And Company; 19.3.1 Company Snapshot; 19.3.2 Revenue Analysis; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Developments; 19.4 Viatris Inc.; 19.4.1 Company Snapshot; 19.4.2 Revenue Analysis; 19.4.3 Company Share Analysis; 19.4.4 Product Portfolio; 19.4.5 Recent Developments; 19.5 Resmed; 19.5.1 Company Snapshot; 19.5.2 Revenue Analysis; 19.5.3 Product Portfolio; 19.5.4 Recent Developments; 19.6 Mallinckrodt; 19.6.1 Company Snapshot; 19.6.2 Revenue Analysis; 19.6.3 Product Portfolio; 19.6.4 Recent Development; 19.7 Koninklijke Philips N.V.; 19.7.1 Company Snapshot; 19.7.2 Revenue Analysis; 19.7.3 Product Portfolio; 19.7.4 Recent Developments; 19.8 Alembic Pharmaceuticals Limited; 19.8.1 Company Snapshot; 19.8.2 Revenue Analysis; 19.8.3 Product Portfolio; 19.8.4 Recent Development; 19.9 Amneal Pharmaceuticals Llc; 19.9.1 Company Snapshot; 19.9.2 Revenue Analysis; 19.9.3 Product Portfolio; 19.9.4 Recent Developments; 19.10 Apotex Inc.; 19.10.1 Company Snapshot; 19.10.2 Product Portfolio; 19.10.3 Recent Development; 19.11 Arbor Pharmaceuticals; 19.11.1 Company Snapshot; 19.11.2 Product Portfolio; 19.11.3 Recent Developments; 19.12 Aurobindo Pharma Usa (A Subsidiary Of Aurobindo Pharma); 19.12.1 Company Snapshot; 19.12.2 Revenue Analysis; 19.12.3 Product Portfolio; 19.12.4 Recent Developments; 19.13 Bmc Medical Co.; 19.13.1 Company Snapshot; 19.13.2 Product Portfolio; 19.13.3 Recent Development; 19.14 Devilbiss Healthcare Llc; 19.14.1 Company Snapshot; 19.14.2 Product Portfolio; 19.15 Dr. Reddy’s Laboratories Ltd.; 19.15.1 Company Snapshot; 19.15.2 Revenue Analysis; 19.15.3 Product Portfolio; 19.15.4 Recent Development; 19.16 Hikma Pharmaceuticals Plc; 19.16.1 Company Snapshot; 19.16.2 Revenue Analysis; 19.16.3 Product Portfolio; 19.16.4 Recent Developments; 19.17 Lupin Pharmaceuticals, Inc. (A Subsidiary Of Lupin); 19.17.1 Company Snapshot; 19.17.2 Revenue Analysis; 19.17.3 Product Portfolio; 19.17.4 Recent Developments; 19.18 Oventus; 19.18.1 Company Snapshot; 19.18.2 Revenue Analysis; 19.18.3 Product Portfolio; 19.18.4 Recent Developments; 19.19 Sanofi-aventis U.S. Llc (A Subsidiary Of Sanofi); 19.19.1 Company Snapshot; 19.19.2 Revenue Analysis; 19.19.3 Product Portfolio; 19.19.4 Recent Developments; 19.20 Somnomed; 19.20.1 Company Snapshot; 19.20.2 Revenue Analysis; 19.20.3 Product Portfolio; 19.20.4 Recent Developments; 19.21 Taj Pharmaceuticals Limited; 19.21.1 Company Snapshot; 19.21.2 Product Portfolio; 19.21.3 Recent Development; 19.22 Taro Pharmaceutical Industries Ltd.; 19.22.1 Company Snapshot; 19.22.2 Revenue Analysis; 19.22.3 Product Portfolio; 19.22.4 Recent Development; 19.23 Teva Pharmaceuticals Usa, Inc. (A Subsidiary Of Teva Pharmaceutical Industries Ltd.); 19.23.1 Company Snapshot; 19.23.2 Revenue Analysis; 19.23.3 Product Portfolio; 19.23.4 Recent Developments
20 Questionnaire
21 Related Reports
List Of Tables: Table 1 North America Sleep Disorder Treatment Market: Pipeline Analysis; Table 2 Generic Drugs For Sleep Disorder Treatment; Table 3 North America Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 4 North America Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 5 North America Sleep Apnea In Sleep Disorder Treatment Market, By Type 2019-2028 (Usd Million) By Region; Table 6 North America Narcolepsy In Sleep Disorder Treatment Market, By Type 2019-2028 (Usd Million) By Region; Table 7 North America Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 8 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Type 2019-2028 (Usd Million) By Region; Table 9 North America Mechanical Therapy In Sleep Disorder Treatment Market, By Type 2019-2028 (Usd Million) By Region; Table 10 North America Surgery In Sleep Disorder Treatment Market, By Type 2019-2028 (Usd Million) By Region; Table 11 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration 2020-2028 (Usd Million); Table 12 North America Oral Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration 2020-2028 (Usd Million); Table 13 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type 2020-2028 (Usd Million); Table 14 North America Branded Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type 2020-2028 (Usd Million); Table 15 North America Sleep Disorder Treatment Market, By Population Type, 2019-2028 (Usd Million); Table 16 North America Sleep Disorder Treatment Market, By End User, 2019-2028 (Usd Million); Table 17 North America Sleep Disorder Treatment Market, By Distribution Channel, 2019-2028 (Usd Million); Table 18 North America Sleep Disorder Treatment Market, By Country, 2019-2028 (Usd Million); Table 19 North America Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 20 North America Insomnia In Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 21 North America Sleep Apnea In Sleep Disorder Treatment Market , By Type 2019-2028 (Usd Million); Table 22 North America Narcolepsy In Sleep Disorder Treatment Market, 2019-2028 (Usd Million); Table 23 North America Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 24 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 25 North America Mechanical Therapy In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 26 North America Surgery In Sleep Disorder Treatment Market, By Treatment 2019-2028 (Usd Million); Table 27 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 28 North America Oral Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 29 North America Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 30 North America Branded Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 31 North America Sleep Disorder Treatment Market, By Population Type, 2019-2028 (Usd Million); Table 32 North America Sleep Disorder Treatment Market, By End User, 2019-2028 (Usd Million); Table 33 North America Sleep Disorder Treatment Market, By Distribution Channel, 2019-2028 (Usd Million); Table 34 U.S. Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 35 U.S. Insomnia In Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 36 U.S. Sleep Apnea In Sleep Disorder Treatment Market , By Type, 2019-2028 (Usd Million); Table 37 U.S. Narcolepsy In Sleep Disorder Treatment Market ,2019-2028 (Usd Million); Table 38 U.S. Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 39 U.S. Pharmacological Therapy In Sleep Disorder Treatment Market, By Treatment , 2019-2028 (Usd Million); Table 40 U.S. Mechanical Therapy In Sleep Disorder Treatment Market, By Treatment 2019-2028 (Usd Million); Table 41 U.S. Surgery In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 42 U.S. Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 43 U.S. Oral Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 44 U.S. Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 45 U.S. Branded Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 46 U.S. Sleep Disorder Treatment Market, By Population Type, 2019-2028 (Usd Million); Table 47 U.S. Sleep Disorder Treatment Market, By End User, 2019-2028 (Usd Million); Table 48 U.S. Sleep Disorder Treatment Market, By Distribution Channel, 2019-2028 (Usd Million); Table 49 Canada Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 50 Canada Insomnia In Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 51 Canada Sleep Apnea In Sleep Disorder Treatment Market , By Type, 2019-2028 (Usd Million); Table 52 Canada Narcolepsy In Sleep Disorder Treatment Market, 2019-2028 (Usd Million); Table 53 Canada Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 54 Canada Pharmacological Therapy In Sleep Disorder Treatment Market, By Treatment 2019-2028 (Usd Million); Table 55 Canada Mechanical Therapy In Sleep Disorder Treatment Market, By Treatment 2019-2028 (Usd Million); Table 56 Canada Surgery In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 57 Canada Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 58 Canada Oral Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 59 Canada Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 60 Canada Branded Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 61 Canada Sleep Disorder Treatment Market, By Population Type, 2019-2028 (Usd Million); Table 62 Canada Sleep Disorder Treatment Market, By End User, 2019-2028 (Usd Million); Table 63 Canada Sleep Disorder Treatment Market, By Distribution Channel, 2019-2028 (Usd Million); Table 64 Mexico Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 65 Mexico Insomnia In Sleep Disorder Treatment Market, By Type, 2019-2028 (Usd Million); Table 66 Mexico Sleep Apnea In Sleep Disorder Treatment Market , By Type, 2019-2028 (Usd Million); Table 67 Mexico Narcolepsy In Sleep Disorder Treatment Market, 2019-2028 (Usd Million); Table 68 Mexico Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 69 Mexico Pharmacological Therapy In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 70 Mexico Mechanical Therapy In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 71 Mexico Surgery In Sleep Disorder Treatment Market, By Treatment, 2019-2028 (Usd Million); Table 72 Mexico Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 73 Mexico Oral Pharmacological Therapy In Sleep Disorder Treatment Market, By Route Of Administration, 2019-2028 (Usd Million); Table 74 Mexico Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 75 Mexico Branded Pharmacological Therapy In Sleep Disorder Treatment Market, By Drugs Type, 2019-2028 (Usd Million); Table 76 Mexico Sleep Disorder Treatment Market, By Population Type, 2019-2028 (Usd Million); Table 77 Mexico Sleep Disorder Treatment Market, By End User, 2019-2028 (Usd Million); Table 78 Mexico Sleep Disorder Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
List Of Figures: Figure 1 North America Sleep Disorder Treatment Market: Segmentation; Figure 2 North America Sleep Disorder Treatment Market: Data Triangulation; Figure 3 North America Sleep Disorder Treatment Market: Droc Analysis; Figure 4 North America Sleep Disorder Treatment Market: North America Vs Regional Market Analysis; Figure 5 North America Sleep Disorder Treatment Market: Company Research Analysis; Figure 6 North America Sleep Disorder Treatment Market: Interview Demographics; Figure 7 North America Sleep Disorder Treatment Market: Dbmr Market Position Grid; Figure 8 North America Sleep Disorder Treatment Market: Market End User Coverage Grid; Figure 9 North America Sleep Disorder Treatment Market: Segmentation; Figure 10 Rising Prevalence Of Sleeping Disorders Is Expected To Drive The North America Sleep Disorder Treatment Market In The Forecast Period Of 2021 To 2028; Figure 11 Insomnia Segment Is Expected To Account For The Largest Share Of The North America Sleep Disorder Treatment Market In 2021 & 2028; Figure 12 Drivers, Restraints, Opportunities And Challenges Of North America Sleep Disorder Treatment Market; Figure 13 Proportion Of American Teens (8- To 12- Year-old) Spending Time With Screen Media In A Day (In Hours); Figure 14 Proportion Of American Teens (8- To 12- Year-old) Spending Time With Screen Media In A Day (In Hours); Figure 15 Proportion Of American Teens (13- To 18- Year-old) Spending Time With Screen Media In A Day (In Hours); Figure 16 North America Sleep Disorder Treatment Market: By Type, 2020; Figure 17 North America Sleep Disorder Treatment Market: By Type, 2020-2028 (Usd Million); Figure 18 North America Sleep Disorder Treatment Market: By Type, Cagr (2020-2028); Figure 19 North America Sleep Disorder Treatment Market: By Type, Lifeline Curve; Figure 20 North America Sleep Disorder Treatment Market: By Treatment, 2020; Figure 21 North America Sleep Disorder Treatment Market: By Treatment, 2020-2028 (Usd Million); Figure 22 North America Sleep Disorder Treatment Market: By Treatment, Cagr (2020-2028); Figure 23 North America Sleep Disorder Treatment Market: By Treatment, Lifeline Curve; Figure 24 North America Sleep Disorder Treatment Market: By Route Of Administration, 2020; Figure 25 North America Sleep Disorder Treatment Market: By Route Of Administration, 2020-2028 (Usd Million); Figure 26 North America Sleep Disorder Treatment Market: By Route Of Administration, Cagr (2020-2028); Figure 27 North America Sleep Disorder Treatment Market: By Route Of Administration, Lifeline Curve; Figure 28 North America Sleep Disorder Treatment Market: By Drugs Type, 2020; Figure 29 North America Sleep Disorder Treatment Market: By Drugs Type, 2020-2028 (Usd Million); Figure 30 North America Sleep Disorder Treatment Market: By Drugs Type, Cagr (2020-2028); Figure 31 North America Sleep Disorder Treatment Market: By Drugs Type, Lifeline Curve; Figure 32 North America Sleep Disorder Treatment Market: By Population Type, 2020; Figure 33 North America Sleep Disorder Treatment Market: By Population Type, 2020-2028 (Usd Million); Figure 34 North America Sleep Disorder Treatment Market: By Population Type, Cagr (2020-2028); Figure 35 North America Sleep Disorder Treatment Market: By Population Type, Lifeline Curve; Figure 36 North America Sleep Disorder Treatment Market: By End User, 2020; Figure 37 North America Sleep Disorder Treatment Market: By End User, 2020-2028 (Usd Million); Figure 38 North America Sleep Disorder Treatment Market: By End User, Cagr (2020-2028); Figure 39 North America Sleep Disorder Treatment Market: By End User, Lifeline Curve; Figure 40 North America Sleep Disorder Treatment Market: By Distribution Channel, 2020; Figure 41 North America Sleep Disorder Treatment Market: By Distribution Channel, 2020-2028 (Usd Million); Figure 42 North America Sleep Disorder Treatment Market: By Distribution Channel, Cagr (2020-2028); Figure 43 North America Sleep Disorder Treatment Market: By Distribution Channel, Lifeline Curve; Figure 44 North America Sleep Disorder Treatment Market: Snapshot (2020); Figure 45 North America Sleep Disorder Treatment Market: By Country (2020); Figure 46 North America Sleep Disorder Treatment Market: By Country (2020 & 2028); Figure 47 North America Sleep Disorder Treatment Market: By Country (2020 & 2028); Figure 48 North America Sleep Disorder Treatment Market: By Type (2020-2028); Figure 49 North America Sleep Disorder Treatment Market: Company Share 2020 (%)